Ken Griffin Prefers Biotech to Large-Caps Like Apple & Priceline

Home › Ken Griffin Prefers Biotech to Large-Caps Like Apple & Priceline

The first thing to know about Citadel and Ken Griffin is that they typically employ a high level of portfolio turnover on a quarterly basis.

15.11	171
15.11	3FLYOVER
15.11	PSA8 - 1ed
15.11	DMC RAVEN 18g
15.11	LOVE or DEAD Blu-ray
15.11	HSGI SURE-GRIP PADDED BELT a-tacs au
15.11	BOUNTY HUNTER
15.11
More »

je.st